Hoth Therapeutics (HOTH) Institutional Ownership → The ProTrader Dashboard is simple to use! (trade demo inside) (From WealthPress) (Ad) Free HOTH Stock Alerts $1.52 +0.14 (+10.14%) (As of 03/28/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Hoth Therapeutics (NASDAQ:HOTH)CurrentInstitutional OwnershipPercentage7.08%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$286,926.31Number ofInstitutional Sellers(last 12 months)0 Get HOTH Insider Trade Alerts Want to know when executives and insiders are buying or selling Hoth Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data HOTH Institutional Buying and Selling by Quarter Ad Crypto 101 MediaMajor Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. Hoth Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails12/18/2023Vanguard Group Inc.38,804$59K0.0%+217.2%0.892% 8/15/2023Integrated Wealth Concepts LLC10,000$30K0.0%N/A0.303% 8/15/2023Citadel Advisors LLC20,428$61K0.0%N/A0.619% 8/11/2023Geode Capital Management LLC24,340$73K0.0%N/A0.738% 5/11/2023Acadian Asset Management LLC39,915$80K0.0%N/A1.209% 2/15/2023Jane Street Group LLC11,122$87K0.0%N/A0.772% Get the Latest News and Ratings for HOTH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hoth Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/2023Armistice Capital LLC140,000$1.09M0.0%N/A9.722% 2/10/2023HRT Financial LP11,532$89K0.0%N/A0.801% 11/15/2022Vanguard Group Inc.942,305$0.33M0.0%+23.2%72.485% 11/14/2022Renaissance Technologies LLC136,045$47K0.0%-13.5%10.563% 8/13/2022Virtu Financial LLC138,213$58K0.0%+453.2%0.429% 8/13/2022Renaissance Technologies LLC157,245$66K0.0%+77.9%0.488% 5/13/2022Renaissance Technologies LLC88,400$61K0.0%-47.1%0.274% 5/13/2022Vanguard Group Inc.764,646$0.53M0.0%+7.7%2.374% 8/16/2021State Street Corp27,100$43K0.0%N/A0.114% 8/13/2021Geode Capital Management LLC79,571$0.13M0.0%+323.4%0.333% 8/13/2021Vanguard Group Inc.706,195$1.13M0.0%+650.7%2.958% 5/21/2021Citadel Advisors LLC79,758$0.16M0.0%+137.4%0.334% 5/19/2021Virtu Financial LLC131,773$0.26M0.0%N/A0.552% 5/18/2021Citadel Advisors LLC79,758$0.16M0.0%+137.4%0.334% 5/17/2021Armistice Capital LLC2,270,000$4.47M0.1%N/A9.509% 5/14/2021XTX Topco Ltd12,888$25K0.0%N/A0.054% 5/13/2021Renaissance Technologies LLC221,000$0.44M0.0%+40.6%0.926% 5/13/2021 Bank of New York Mellon Corp26,555$52K0.0%N/A0.111% 5/7/2021BlackRock Inc.24,502$48K0.0%-23.8%0.108% 2/10/2021Renaissance Technologies LLC157,190$0.37M0.0%+98.5%1.170% 2/5/2021BlackRock Inc.32,146$76K0.0%+20.3%0.239% 9/10/2020Two Sigma Securities LLC10,768$28K0.0%N/A0.080% 8/14/2020Sabby Management LLC68,681$0.18M0.0%N/A0.512% 8/12/2020Goldman Sachs Group Inc.16,027$41K0.0%N/A0.119% 8/11/2020Magnus Financial Group LLC13,000$34K0.0%N/A0.097% 8/3/2020Game Plan Financial Advisors LLC10,750$28K0.0%N/A0.080% 7/16/2020Wedbush Securities Inc.22,856$59K0.0%N/A0.170% (Data available from 1/1/2016 forward) HOTH Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of HOTH shares? During the previous two years, 10 institutional investors and hedge funds held shares of Hoth Therapeutics. The most heavily invested institutionals were Armistice Capital LLC ($1.09M), HRT Financial LP ($89K), Jane Street Group LLC ($87K), Acadian Asset Management LLC ($80K), Geode Capital Management LLC ($73K), Citadel Advisors LLC ($61K), and Vanguard Group Inc. ($59K).Learn more on HOTH's institutional investors. What percentage of Hoth Therapeutics stock is owned by institutional investors? 7.08% of Hoth Therapeutics stock is owned by institutional investors. Learn more on HOTH's institutional investor holdings. Which institutional investors have been buying Hoth Therapeutics stock? Of the 10 institutional investors that purchased Hoth Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vanguard Group Inc. ($0.26M), Armistice Capital LLC ($0.14M), Virtu Financial LLC ($0.11M), Renaissance Technologies LLC ($68.85K), Acadian Asset Management LLC ($39.92K), Geode Capital Management LLC ($24.34K), and Citadel Advisors LLC ($20.43K). How much institutional buying is happening at Hoth Therapeutics? Institutional investors have bought a total of 698,242 shares in the last 24 months. This purchase volume represents approximately $5.95M in transactions. Which Hoth Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Hoth Therapeutics stock in the last 24 months: Renaissance Technologies LLC ($99.90K). How much institutional selling is happening at Hoth Therapeutics? Institutional investors have sold a total of 99,900 shares in the last 24 months. This volume of shares sold represents approximately $1.55M in transactions. Related Companies: Pulmatrix Major Shareholders Kineta Major Shareholders Protagenic Therapeutics Major Shareholders Biofrontera Major Shareholders NexImmune Major Shareholders GT Biopharma Major Shareholders Bright Minds Biosciences Major Shareholders Oragenics Major Shareholders Soligenix Major Shareholders Enveric Biosciences Major Shareholders This page (NASDAQ:HOTH) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryAI Cracks Open Largest Untapped Energy Reserve on EarthBanyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyOnly a fool would buy Nvidia today… Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hoth Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.